scispace - formally typeset
A

Anton F.P.M. de Goeij

Researcher at Maastricht University

Publications -  49
Citations -  4060

Anton F.P.M. de Goeij is an academic researcher from Maastricht University. The author has contributed to research in topics: Colorectal cancer & Diet and cancer. The author has an hindex of 33, co-authored 49 publications receiving 3825 citations. Previous affiliations of Anton F.P.M. de Goeij include Maastricht University Medical Centre.

Papers
More filters
Journal ArticleDOI

Surviving in a Marine Desert: The Sponge Loop Retains Resources Within Coral Reefs

TL;DR: The DOM-sponge-fauna pathway explains why biological hot spots such as coral reefs persist in oligotrophic seas—the reef’s paradox—and has implications for reef ecosystem functioning and conservation strategies.
Journal ArticleDOI

Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability

TL;DR: Evidence was found that these chromosomal abnormalities occurred in specific combinations of a few abnormalities rather than as a mere accumulation of events, indicating the existence of multiple independent chromosomal instability pathways of colorectal cancer progression.
Journal ArticleDOI

K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study.

TL;DR: The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial coloreCTal cancer, and could imply that K-ra mutations are more probably involved in environmental mechanisms of colOREctal carcinogenesis.
Journal Article

Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.

TL;DR: F folate and alcohol intake may be associated with changes in promoter hypermethylation in CRC, and the number of CRCs with at least one gene methylated was higher in the low folate intake/high alcohol intake group when compared with the high folate Intake/low alcohol Intake group.
Journal ArticleDOI

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low‐grade serous tumours

TL;DR: The finding that at least 60% of serous borderline tumours harbour mutations in two members of the ERK‐MAP‐kinase pathway compared with 12% of high‐grade serous carcinomas (BRAF 0%, KRAS 12%) indicates that the majority of serious borderline tumoured tumours do not progress to serious carcinomas.